Variables | Subgroup | Number of studies | Sensitivity estimate (95% CI) | P value | Specificity estimate (95% CI) | P value |
---|---|---|---|---|---|---|
Research type | Â | Â | Â | Â | Â | Â |
 | Retrospectively | 11 | 0.89 (0.84–0.94) | 0.27 | 0.47 (0.33–0.62) | 0.01 |
 | Prospectively | 5 | 0.81 (0.69–0.92) |  | 0.82 (0.67–0.97) |  |
Reference Standard | Â | Â | Â | 0.01 | Â | 0.01 |
 | Clinical Diagnosis | 11 | 0.85 (0.79–0.91) |  | 0.70 (0.59–0.82) |  |
 | CMT | 5 | 0.91 (0.83–0.98) |  | 0.32 (0.17–0.48) |  |
Population | Â | Â | Â | 0.18 | Â | 0.27 |
 | Adults | 6 | 0.84 (0.73–0.95) |  | 0.76 (0.65–0.88) |  |
 | Children | 5 | 0.85 (0.74–0.95) |  | 0.51 (0.36–0.66) |  |
Neutropeniaa | Â | Â | Â | 0.01 | Â | 0.51 |
 | Yes | 3 | 0.76 (0.58–0.93) |  | 0.67 (0.35–1.00) |  |
 | No | 8 | 0.89 (0.83–0.94) |  | 0.51 (0.30–0.73) |  |
HSCTb | Â | Â | Â | 0.4 | Â | 0.71 |
 | Yes | 5 | 0.90 (0.82–0.97) |  | 0.65 (0.42–0.88) |  |
 | No | 5 | 0.84 (0.74–0.93) |  | 0.54 (0.33–0.76) |  |